TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/26/24 16:05 | 3/22/24 | PHAT | Phathom Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Curran Terrie | NJ | DO | P,Chief | S | -154 | 9.11 | 0 | -17 | -4 | 415 | D | ||||||||||||||
3/3/23 18:59 | 3/1/23 | PHAT | Phathom Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Curran Terrie | NJ | DO | P,Chief | S | -12 | 8.54 | 0 | -1 | -1 | 178 | D | ||||||||||||||
1/20/23 19:39 | 1/20/23 | PHAT | Phathom Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Curran Terrie | NJ | DO | P,Chief | S.d | -48 | 8.20 | 0 | -6 | -3 | 179 | D | ||||||||||||||
11/23/22 16:07 | 11/21/22 | PHAT | Phathom Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Curran Terrie | NJ | DO | P,Chief | S | -15 | 9.60 | 0 | -2 | -2 | 86 | D | ||||||||||||||
9/13/21 16:11 | 9/9/21 | MYOV | Myovant Sciences Ltd. | CA | Health | Drug | Pharmaceutical Preparations | Curran Terrie | CA | D | S.d | -124 | 25.58 | 0 | -5 | -100 | 0 | D | |||||||||||||||
9/3/21 16:25 | 9/1/21 | MYOV | Myovant Sciences Ltd. | CA | Health | Drug | Pharmaceutical Preparations | Curran Terrie | CA | D | S.dm | -1,214 | 25.02 | 0 | -49 | -100 | 0 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |